[go: up one dir, main page]

FI963719A0 - Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista - Google Patents

Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista

Info

Publication number
FI963719A0
FI963719A0 FI963719A FI963719A FI963719A0 FI 963719 A0 FI963719 A0 FI 963719A0 FI 963719 A FI963719 A FI 963719A FI 963719 A FI963719 A FI 963719A FI 963719 A0 FI963719 A0 FI 963719A0
Authority
FI
Finland
Prior art keywords
blood plasma
fractionation
human blood
proteins
fractions formed
Prior art date
Application number
FI963719A
Other languages
English (en)
Swedish (sv)
Other versions
FI963719A7 (fi
Inventor
Hanspeter Amstutz
Peter G Lerch
Jean-Jacques Morgenthaler
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of FI963719A0 publication Critical patent/FI963719A0/fi
Publication of FI963719A7 publication Critical patent/FI963719A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
FI963719A 1995-09-22 1996-09-19 Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista FI963719A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810596A EP0764658B1 (de) 1995-09-22 1995-09-22 Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen

Publications (2)

Publication Number Publication Date
FI963719A0 true FI963719A0 (fi) 1996-09-19
FI963719A7 FI963719A7 (fi) 1997-03-23

Family

ID=8221797

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963719A FI963719A7 (fi) 1995-09-22 1996-09-19 Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista

Country Status (21)

Country Link
EP (1) EP0764658B1 (fi)
JP (1) JP2952572B2 (fi)
KR (1) KR100236762B1 (fi)
CN (1) CN1089609C (fi)
AT (1) ATE211486T1 (fi)
AU (1) AU715427B2 (fi)
BR (1) BR9603826A (fi)
CA (1) CA2185617A1 (fi)
CZ (1) CZ286885B6 (fi)
DE (1) DE59509979D1 (fi)
DK (1) DK0764658T3 (fi)
ES (1) ES2170788T3 (fi)
FI (1) FI963719A7 (fi)
HU (1) HUP9602570A3 (fi)
MX (1) MX9604256A (fi)
NO (1) NO963952L (fi)
NZ (1) NZ299394A (fi)
PL (1) PL316126A1 (fi)
PT (1) PT764658E (fi)
RO (1) RO117921B1 (fi)
RU (1) RU2157240C2 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293119B1 (it) * 1997-06-12 1999-02-11 Mini Ricerca Scient Tecnolog Processo per la separazione di immunoglobuline specifiche da plasma standard e loro utilizzo per trattamenti terapeutici
CN1520885A (zh) 1997-10-23 2004-08-18 ������ҩ��ʽ���� 可室温贮存的免疫球蛋白静脉注射制剂
RU2239453C2 (ru) * 2002-12-03 2004-11-10 Федеральное государственное унитарное предприятие " Научно-производственное объединение по медицинским иммунобиологическим препаратам " Микроген" Препарат иммуноглобулина человека против цитомегаловируса и способ его получения
RU2252780C1 (ru) * 2004-04-30 2005-05-27 Аваков Анатолий Эдуардович Способ получения иммуноглобулинового препарата
PT1786273T (pt) 2004-08-20 2019-02-19 The American Nat Red Cross Esquemas de isolamento e purificação de proteínas sequenciais por cromatografia de afinidade
DE102005023155A1 (de) * 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
EP2233499A1 (en) 2009-03-26 2010-09-29 CSL Behring AG Antibody composition with altered Fab sialylation
WO2010148117A1 (en) * 2009-06-17 2010-12-23 Scantibodies Laboratory, Inc. Therapeutic and diagnostic affinity purified specific polyclonal antibodies
ITRM20090558A1 (it) * 2009-11-03 2011-05-04 Michele Pitaro Procedimento per la produzione di immunoglobuline estratte da plasma umano ad uso terapeutico neutralizzanti il virus di epstein barr e farmaco contenente dette immunoglobuline
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
KR20130093607A (ko) * 2010-07-23 2013-08-22 백스터 인터내셔널 인코포레이티드 혈장으로부터 인터-알파-억제제 단백질 (iaip)의 제조
ES2531459B1 (es) * 2013-06-10 2015-12-28 Antonio VILA SANJURJO Método para la separación física de "traductomas" convolucionados
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
KR20150115639A (ko) * 2014-04-04 2015-10-14 전숙영 치료용 면역글로불린 제제 제조에 사용되는 산성 완충액, 이를 이용한 치료용 면역글로불린 제제 제조방법 및 이 제조방법으로 제조된 치료용 면역글로불린 제제
GB201413227D0 (en) * 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232004A (en) * 1977-09-21 1980-11-04 American National Red Cross Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
IL90281A (en) * 1988-06-06 1994-10-07 Miles Inc Preparations containing MGI antibodies

Also Published As

Publication number Publication date
CZ286885B6 (en) 2000-07-12
ATE211486T1 (de) 2002-01-15
PT764658E (pt) 2002-06-28
PL316126A1 (en) 1997-04-01
EP0764658A1 (de) 1997-03-26
ES2170788T3 (es) 2002-08-16
DE59509979D1 (de) 2002-02-07
EP0764658B1 (de) 2002-01-02
CN1089609C (zh) 2002-08-28
CA2185617A1 (en) 1997-03-23
CN1153063A (zh) 1997-07-02
KR970015745A (ko) 1997-04-28
AU715427B2 (en) 2000-02-03
HUP9602570A3 (en) 1998-01-28
MX9604256A (es) 1998-04-30
CZ274896A3 (en) 1997-04-16
JPH09124508A (ja) 1997-05-13
HU9602570D0 (en) 1996-11-28
NZ299394A (en) 1997-12-19
HUP9602570A2 (en) 1997-08-28
BR9603826A (pt) 1998-06-02
NO963952L (no) 1997-03-24
NO963952D0 (no) 1996-09-20
FI963719A7 (fi) 1997-03-23
KR100236762B1 (ko) 2000-01-15
DK0764658T3 (da) 2002-04-22
AU6572596A (en) 1997-04-10
JP2952572B2 (ja) 1999-09-27
RU2157240C2 (ru) 2000-10-10
RO117921B1 (ro) 2002-09-30

Similar Documents

Publication Publication Date Title
FI963719A0 (fi) Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista
CA2006865A1 (en) Humanized immunoglobulins and their production and use
NO913186D0 (no) Fremgangsmaate for anvendelse og syntese av peptider.
WO2003059935A3 (en) Methods for purifying protein
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
MX9603637A (es) Purificacion de anticuerpo.
DK0408029T3 (da) Fremgangsmåde til fraktionering af plasmaprotein
DE3484673D1 (de) Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen.
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
DE3361733D1 (en) Process for isolating immunoglobulins from the colostrum
DE69028513D1 (de) Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
DE50011030D1 (de) Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
AU7203194A (en) Bispecific human monoclonal antibodies specific for human immunodeficiency virus
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
DK0763100T3 (da) Fremgangsmåde til rensning af Clostridium difficile-texin og fremstilling af monospecifkke antistoffer
RU95120418A (ru) Способ получения альфа-фетопротеина
SE9000931D0 (sv) Antikroppar mot proteiner
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
Skvaril et al. In vitro characterization of immunoglobulins for intravenous use
ATE184315T1 (de) Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.
SE7904276L (sv) Renat cancerassocierat protein
WO1998056822A3 (en) Process for the separation of specific immunoglobulins from standard plasma